Impacto de los cambios en la prescripción del tratamiento anticoagulante en laincidencia de ictus

Schnabel, 2015, 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study, Lancet, 386, 154, 10.1016/S0140-6736(14)61774-8 Go As, Hylek, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, 285, 2370, 10.1001/jama.285.18.2370 Barrios, 2012, Patients with atrial fibrillation in a primary care setting: Val-FAAP study, Rev Esp Cardiol, 65, 47, 10.1016/j.recesp.2011.08.008 Gómez-Doblas, 2014, Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE, Rev Esp Cardiol, 67, 259, 10.1016/j.recesp.2013.07.015 Masjuán, 2014, Manejo actual del tratamiento antitrombótico en pacientes con fibrilación auricular no valvular y antecedentes de ictus o ataque isquémico transitorio, Rev Neurol, 59, 25 Hindricks G, Potpara T, Dagres N, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020 Aug 29:ehaa612. doi: 10.1093/eurheartj/ehaa612. Epub ahead of print. Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Ruff, 2014, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials, Lancet, 383, 955, 10.1016/S0140-6736(13)62343-0 Perreault, 2020, Oral anticoagulant prescripción trends, profile use, and determinants of adherence in patients with atrial fibrillation, Pharmacotherapy, 40, 40, 10.1002/phar.2350 Lee, 2020, Effectiveness and safety of direct oral anticoagulants in relación to temporal changes in their use, Circ Cardiovasc Qual Outcomes, 13, e005894, 10.1161/CIRCOUTCOMES.119.005894 Llisterri Caro, 2019, Utilización de los anticoagulantes orales de acción directa en Atención Primaria de España. Posicionamiento de SEMERGEN ante la situación actual, Semergen, 45, 413, 10.1016/j.semerg.2019.06.002 Cowan, 2018, A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation, Eur Heart J, 39, 2975, 10.1093/eurheartj/ehy411 Forslund, 2018, Improved stroke prevention in atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants, Stroke, 49, 2122, 10.1161/STROKEAHA.118.021990 Maggioni, 2020, Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million people, Am Heart J, 220, 12, 10.1016/j.ahj.2019.10.017 Rubio-Terrés, 2016, Cost-effectiveness analysis of rivaroxaban versus acenocoumarol in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain, JHEOR, 4, 19, 10.36469/9823 Barón Esquivias, 2015, Análisis coste-efectividad de apixabán frente a acenocumarol en la prevención del ictus en pacientes con fibrilación auricular no valvular en España, Rev Esp Cardiol, 68, 680, 10.1016/j.recesp.2014.08.010 González-Juanatey, 2012, Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España, Rev Esp Cardiol, 65, 901, 10.1016/j.recesp.2012.06.006 Lekuona, 2019, ¿El uso de edoxabán sería coste-efectivo para la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular en España? Rev Esp Cardiol, 72, 398 Freixa-Pamias, 2019, Impact of an integral assistance model between primary care and cardiology on the management of patients with ischemic heart disease or atrial fibrillation, J Comp Eff Res, 8, 103, 10.2217/cer-2018-0088 Freixa-Pamias, 2019, Mejorar la atención médica mediante un modelo integrado de asistencia para pacientes con cardiopatía isquémica o fibrilación auricular, Rev Esp Cardiol, 72, 779, 10.1016/j.recesp.2018.09.011 Freixa-Pamias R, Blanch Gràcia P, Rodriguez Latre ML. Impact of prescripción patterns of antithrombotic treatment on atrial fibrillation-related strokes. Curr Med Res Opin. 2021. https://doi.org/10.1080/03007995.2020.1865892. Cosin-Sales, 2020, Impact of different models of improvement of continuity of care on lipid control and the delay of visits to cardiology, Future Cardiol, 16, 33, 10.2217/fca-2018-0083 Matías-Guiu, 2007, La investigación en epidemiologia del ictus en España, Estudios de base poblacional o utilización de aproximaciones a partir del CMBD? Rev Esp Cardiol, 60, 563 Marrugat, 2007, Estimación de la incidencia poblacional y la mortalidad de la enfermedad cerebrovascular establecida isquémica y hemorrâgica en 2002, Rev Esp Cardiol, 60, 573, 10.1157/13107113 Orlowski, 2021, Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation, Heart, 107, 47, 10.1136/heartjnl-2020-317006 Sociedad Española de Neurología. El atlas del ictus. España 2019. Disponible en: https://www.sen.es/images/2020/atlas/Atlas_del_Ictus_de_Espana_version_web. pdf. Consultado 16 Feb 2021. Suárez Fernández, 2018, Seguimiento de las recomendaciones del Informe de Posicionamiento Terapéutico sobre el tratamiento con anticoagulantes orales en pacientes ancianos con fibrilación auricular, Estudio ESPARTA. Med Clin (Barc), 151, 8, 10.1016/j.medcli.2017.07.025 Steinberg, 2018, Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants: results from ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II), J Am Heart Assoc, 7, e007633, 10.1161/JAHA.117.007633 Escobar, 2019, Anticoagulantes orales directos frente a antagonistas de la vitamina K en pacientes con fibrilación auricular de la prâctica clînica: revision sistemâtica y metanâlisis, Rev Esp Cardiol, 72, 305, 10.1016/j.recesp.2018.02.023 Fernández, 2020, The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation, J Comp Eff Res, 9, 509, 10.2217/cer-2019-0197